New Advances in the Management of Idiopathic Pulmonary Fibrosis

8:00 a.m. – 12:30 p.m.

This program is designed to provide knowledge on new medical advances for IPF that include recent approval of therapies. In addition, it will provide information about different clinical trials that are ongoing to improve the survival rate and quality of IPF patients.

Register online.

King of Prussia, United States of America

To download a printer-friendly version of the program, click here